As her eyesight grows dimmer, Kelli Deister finds herself constantly having to start over again in learning how to navigate her world.

Ms. Deister, 52, was diagnosed four years ago with retinitis pigmentosa, a genetic form of progressive blindness. Even though she already had struggled for years with balance, hearing and vision problems from a rare immune disorder known as Cogan’s syndrome, the news that she had RP “changed my whole life.”

She asked her ophthalmologist to describe the disorder. “She said it leads to blindness. I asked her how much time do I have. She said there is no time frame. Some lose it fast, and some lose it slow.”

At this point, Ms. Deister, who lives in an apartment complex in Sunbury, Pa., north of Harrisburg, has vision of 20/400 and is no longer able to work. She uses aides to help her shop at the grocery store. She uses a lighted magnification device to read. And she has learned how to cook and do household chores with training she got at Blind and Vision Rehabilitation Services of Pittsburgh.

Advertise with us

About 100,000 Americans have some form of RP, which gradually destroys the rods and cones that make up the eye’s photoreceptors. The fact that RP patients sometimes take years to go blind has led to a flurry of research around the world, all aimed at trying to slow down or halt this gradual loss of sight.

A company called Second Sight in California already has installed electronic implants in the retinas of more than 100 RP patients. Others are exploring genetic therapy for the disease, including the University of Pittsburgh’s Igor Nasonkin, who has recently learned how to grow a 3D layer of early human retinal cells in the laboratory, with hopes of one day implanting them in people with damaged retinas.

We are born with about 120 million light-sensing rods and 6 to 7 million color-sensing cones packed into the retina, a tissue layer at the back of the eye that is less than the thickness of a fingernail.

At a microscopic level, the retina is a highly complex structure. When light enters the eye, it strikes the rods and cones at the back of the retina, and the resulting signals are then sent forward through several other layers until they reach the ganglion cells, whose thready axons bundle together to form the optic nerve.

The optic nerve sends visual signals to the brain, which then processes the information to create the scenes that we see.

Advertise with us

In RP, the rods and then the cones are lost from the outside in, so that vision shrinks toward the center. In her case, Ms. Deister said, she can no longer see her hands in her peripheral vision when she holds them on either side of her temples.

The treatment that is furthest along is Second Sight’s retinal implants. The implant sits on the retina’s ganglion cells, which form the optic nerve, and pick up light signals from a camera centered over the bridge of the nose, said Robert Greenberg, president and CEO of the company. Twenty-eight of the first 30 implants are still working more than five years after the surgery, he said, and a new model known as the Argus II provides a more nuanced visual signal.

Still, Dr. Greenberg noted, Second Sight does not claim to restore people’s vision to its normal state. Instead, it creates a pattern of light and darkness that people can interpret to guide them through their environments.

“I describe it as looking like a blurry television. It’s fairly low resolution, but it can help people locate objects, read large letters and orient themselves in a room to find a door or window.” The vision also is in black and white, although new software for the unit’s signal processor has produced rudimentary color vision for some patients.

Despite the fairly crude vision, which averages 20/1000, RP patients who have received the implants “almost universally describe it as life changing,” he said. “They’ll say, ‘You don’t understand what it’s like to be completely blind and not even know if it’s light or dark, and get some vision back.’ ”

Advertise with us

Another group at Stanford University has designed an implant that it hopes to start testing on human patients in France next year.

The Stanford implant will sit in a different layer of the retina in between the damaged photoreceptors and the ganglion cells. Georges Goetz, a graduate student in the lab of Stanford professor Daniel Palanker, said that the group hopes to avoid some of the streakiness in the visual field that some Second Sight patients have reported by using this other layer of the retina.

Even though he has high hopes for the Stanford implant, Mr. Goetz said that the best solution in the future would be some sort of biological therapy that could help restore vision. “Being able to go back to the [eye’s] biological building blocks and get them to integrate [with the patient’s eye] would be hard to beat in terms of performance.”

The challenge, he said, is getting transplanted cells to make connections with the patient’s already mature eye cells.

One way to tackle that challenge, some groups say, is not to rely on human genes at all.

Advertise with us

Using a technique known as optogenetics, some researchers are giving animals genes derived from bacteria that make light-sensitive proteins. Using a harmless virus as a delivery vehicle, the researchers have managed to insert the bacterial genes in the retinas of visually impaired rodents and demonstrate that they regain some of their sight, said Botond Roska, a professor at the Friedrich Miescher Institute in Basel, Switzerland, who led the experiments. He and researchers at the Vision Institute of Paris also inserted the bacterial genes in human retinas taken from cadavers, and showed they could detect patterns of light.

Working with a French gene therapy company, GenSight, the researchers hope to test the optogenetics therapy on human patients in one to three years.

Pitt’s Mr. Nasonkin, who has a doctorate in human genetics and is director of Pitt’s Retinal Repair Laboratory, doesn’t want to pinpoint when his techniques might be tried in human patients, but said other kinds of human tissue transplants in the eye have paved the way for his group’s work.

The lab’s success in growing multilayered, immature human retinal cells raises hopes that they will be able to make connections with a patient’s existing eye cells, he said. The next step will be seeking grant money to allow his lab-produced cells to be implanted in rodents in the lab of his collaborator, Magdalene Seiler, at the University of California Irvine.

Mr. Nasonkin’s lab, which has received dedicated funding from Pittsburgh eye surgeon E. Ronald Salvitti, began with a line of embyronic stem cells from the University of Wisconsin. These cells are able to develop into many different types of cells in the body, and his lab was able to coax them into becoming early-stage retinal cells. Even more important, they then formed their own discrete layers of different kinds of retinal cells, mimicking what happens in human development.

Advertise with us

“It looks like if you push cells to a certain stage,” he said, “they can self-assemble as long as you feed them the right nutrition.” And that means scientists may soon be able to create a complete “retinal patch” for people with RP or other diseases.

Eventually, he envisions a retinal eye bank derived from adult stem cells that will contain enough different types of human tissue to be compatible with most people’s immune systems.

All of that fascinates Ms. Deister, even though she is not planning to enroll in any of the experimental trials for now.

Instead, she is focusing on how to cope with her growing blindness, as well as being deaf in one ear and continuing to have balance problems.

Having a strong support network from her sisters and her married daughter has been vital, she said.

Advertise with us

So is having the right philosophy about life − a philosophy she developed while writing several inspirational books.

“I’ve gone through depression and anxiety, but throughout it all, what’s pulled me through the most is that I have a model in my life. In every storm in your life, there is a jewel you can find. If I can gather one jewel from every storm, and store it in my heart, then I can use it again, and it helps bring me back up to an even keel.”

Mark Roth: mroth@post-gazette.com, 412-263-1130 or on Twitter @markomar